GenMont Biotech (Taiwan) Alpha and Beta Analysis

3164 Stock  TWD 20.05  0.10  0.50%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as GenMont Biotech. It also helps investors analyze the systematic and unsystematic risks associated with investing in GenMont Biotech over a specified time horizon. Remember, high GenMont Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to GenMont Biotech's market risk premium analysis include:
Beta
(0.03)
Alpha
(0.21)
Risk
0.87
Sharpe Ratio
(0.30)
Expected Return
(0.26)
Please note that although GenMont Biotech alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, GenMont Biotech did 0.21  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of GenMont Biotech stock's relative risk over its benchmark. GenMont Biotech has a beta of 0.03  . As returns on the market increase, returns on owning GenMont Biotech are expected to decrease at a much lower rate. During the bear market, GenMont Biotech is likely to outperform the market. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out GenMont Biotech Backtesting, GenMont Biotech Valuation, GenMont Biotech Correlation, GenMont Biotech Hype Analysis, GenMont Biotech Volatility, GenMont Biotech History and analyze GenMont Biotech Performance.

GenMont Biotech Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. GenMont Biotech market risk premium is the additional return an investor will receive from holding GenMont Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in GenMont Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate GenMont Biotech's performance over market.
α-0.21   β-0.03

GenMont Biotech expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of GenMont Biotech's Buy-and-hold return. Our buy-and-hold chart shows how GenMont Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

GenMont Biotech Market Price Analysis

Market price analysis indicators help investors to evaluate how GenMont Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GenMont Biotech shares will generate the highest return on investment. By understating and applying GenMont Biotech stock market price indicators, traders can identify GenMont Biotech position entry and exit signals to maximize returns.

GenMont Biotech Return and Market Media

The median price of GenMont Biotech for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 is 22.7 with a coefficient of variation of 4.66. The daily time series for the period is distributed with a sample standard deviation of 1.04, arithmetic mean of 22.27, and mean deviation of 0.85. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About GenMont Biotech Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including GenMont or other stocks. Alpha measures the amount that position in GenMont Biotech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GenMont Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GenMont Biotech's short interest history, or implied volatility extrapolated from GenMont Biotech options trading.

Build Portfolio with GenMont Biotech

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for GenMont Stock Analysis

When running GenMont Biotech's price analysis, check to measure GenMont Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GenMont Biotech is operating at the current time. Most of GenMont Biotech's value examination focuses on studying past and present price action to predict the probability of GenMont Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GenMont Biotech's price. Additionally, you may evaluate how the addition of GenMont Biotech to your portfolios can decrease your overall portfolio volatility.